Business_Finance - Bio, News, Photos - Washington Times
Skip to content

Business_Finance

Latest Stories

martin_shkreli_trial_51586.jpg

martin_shkreli_trial_51586.jpg

Martin Shkreli, left, talks with reporters while standing next to his attorney Benjamin Brafman after leaving federal court in New York, Friday, Aug. 4, 2017. The former pharmaceutical CEO has been convicted on federal charges he deceived investors in a pair of failed hedge funds. A Brooklyn jury deliberated five days before finding Shkreli guilty on Friday on three of eight counts. (AP Photo/Seth Wenig)

martin_shkreli_trial_73128.jpg

martin_shkreli_trial_73128.jpg

Martin Shkreli talks with reporters after leaving federal court in New York, Friday, Aug. 4, 2017. Shkreli, the eccentric former pharmaceutical CEO notorious for a price-gouging scandal and for his snide "Pharma Bro" persona on social media, was convicted Friday on federal charges he deceived investors in a pair of failed hedge funds. (AP Photo/Seth Wenig)

martin_shkreli_trial_75124.jpg

martin_shkreli_trial_75124.jpg

Martin Shkreli, center, leaves federal court in New York, Friday, Aug. 4, 2017. The former pharmaceutical CEO has been convicted on federal charges he deceived investors in a pair of failed hedge funds. A Brooklyn jury deliberated five days before finding Shkreli guilty on Friday on three of eight counts. (AP Photo/Seth Wenig)

martin_shkreli_trial_78968.jpg

martin_shkreli_trial_78968.jpg

Martin Shkreli, center, leaves federal court in New York, Friday, Aug. 4, 2017. Shkreli, the eccentric former pharmaceutical CEO notorious for a price-gouging scandal and for his snide "Pharma Bro" persona on social media, was convicted Friday on federal charges he deceived investors in a pair of failed hedge funds. (AP Photo/Seth Wenig)

martin_shkreli_trial_78692.jpg

martin_shkreli_trial_78692.jpg

Martin Shkreli arrives at federal court in New York, Friday, Aug. 4, 2017. Jurors are starting their fifth day of deliberations at the federal securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Seth Wenig)

martin_shkreli_trial_78138.jpg

martin_shkreli_trial_78138.jpg

Martin Shkreli arrives at federal court in New York, Friday, Aug. 4, 2017. Jurors are starting their fifth day of deliberations at the federal securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Seth Wenig)

martin_shkreli_trial_12718.jpg

martin_shkreli_trial_12718.jpg

Martin Shkreli arrives at federal court in New York, Friday, Aug. 4, 2017. Jurors are starting their fifth day of deliberations at the federal securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Seth Wenig)

martin_shkreli_trial_43898.jpg

martin_shkreli_trial_43898.jpg

Martin Shkreli arrives at federal court in New York, Friday, Aug. 4, 2017. Jurors are starting their fifth day of deliberations at the federal securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Seth Wenig)

martin_shkreli_trial_07441.jpg

martin_shkreli_trial_07441.jpg

Martin Shkreli arrives at federal court in New York, Thursday, Aug. 3, 2017. Jurors are starting their fourth day of deliberations at the federal securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Seth Wenig)

martin_shkreli_trial_40046.jpg

martin_shkreli_trial_40046.jpg

Former pharmaceutical company CEO Martin Shkreli, second from left, walks out of federal court with his legal team Thursday, Aug. 3, 2017, in New York. Jurors were on their fourth day of deliberations Thursday at the securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Julie Jacobson)

martin_shkreli_trial_76591.jpg

martin_shkreli_trial_76591.jpg

Former pharmaceutical company CEO Martin Shkreli stands at an intersection after leaving federal court with his legal team, Thursday, Aug. 3, 2017, in New York. Jurors were on their fourth day of deliberations on Thursday at the securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Julie Jacobson)

martin_shkreli_trial_15039.jpg

martin_shkreli_trial_15039.jpg

Former pharmaceutical company CEO Martin Shkreli, center, walks out of federal court with members of his legal team, Thursday, Aug. 3, 2017, in New York. Jurors were on their fourth day of deliberations on Thursday at the securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Julie Jacobson)

martin_shkreli_trial_62090.jpg

martin_shkreli_trial_62090.jpg

Former pharmaceutical company CEO Martin Shkreli, center, walks out of federal court with members of his legal team Thursday, Aug. 3, 2017, in New York. Jurors were on their fourth day of deliberations on Thursday at the securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Julie Jacobson)

martin_shkreli_trial_82566.jpg

martin_shkreli_trial_82566.jpg

Former pharmaceutical company CEO Martin Shkreli, right, walks out of federal court with members of his legal team, Thursday, Aug. 3, 2017, in New York. Jurors were on their fourth day of deliberations on Thursday at the securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Julie Jacobson)

martin_shkreli_trial_36936.jpg

martin_shkreli_trial_36936.jpg

Former pharmaceutical company CEO Martin Shkreli, left, walks out of federal court with his attorney Benjamin Brafman, Thursday, Aug. 3, 2017, in New York. Jurors were on their fourth day of deliberations Thursday at the securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Julie Jacobson)

japan_toyota_mazda_24185.jpg

japan_toyota_mazda_24185.jpg

Toyota Motor Corp. President Akio Toyoda, left, and Mazda Motor Corp. President Masamichi Kogai, pose for media prior to a press conference in Tokyo Friday, Aug. 4, 2017. Japanese automakers Toyota Motor Corp. and Mazda Motor Corp. said Friday they plan to spend $1.6 billion to set up a joint-venture auto manufacturing plant in the U.S. — a move that will create up to 4,000 jobs. (AP Photo/Eugene Hoshiko)

japan_toyota_mazda_52559.jpg

japan_toyota_mazda_52559.jpg

Logos of Toyota Motor Corp., bottom, and Mazda Motor Corp., top, are placed prior to a press conference in Tokyo Friday, Aug. 4, 2017. (AP Photo/Eugene Hoshiko)

japan_toyota_mazda_86187.jpg

japan_toyota_mazda_86187.jpg

Toyota Motor Corp. President Akio Toyoda, left, and Mazda Motor Corp. President Masamichi Kogai shake hands after a press conference in Tokyo Friday, Aug. 4, 2017. Japanese automakers Toyota Motor Corp. and Mazda Motor Corp. said Friday they plan to spend $1.6 billion to set up a joint-venture auto manufacturing plant in the U.S. — a move that will create up to 4,000 jobs. (AP Photo/Eugene Hoshiko)

japan_toyota_mazda_65605.jpg

japan_toyota_mazda_65605.jpg

Toyota Motor Corp. President Akio Toyoda, left, and Mazda Motor Corp. President Masamichi Kogai answer a question during a press conference in Tokyo Friday, Aug. 4, 2017. Japanese automakers Toyota Motor Corp. and Mazda Motor Corp. said Friday they plan to spend $1.6 billion to set up a joint-venture auto manufacturing plant in the U.S. — a move that will create up to 4,000 jobs. (AP Photo/Eugene Hoshiko)

japan_toyota_mazda_56107.jpg

japan_toyota_mazda_56107.jpg

Staffs explain to journalists at the stage for a joint presser of Toyota Motor Corp. , left, and Mazda Motor Corp. , right, prior to a press conference in Tokyo Friday, Aug. 4, 2017. Japanese automakers Toyota Motor Corp. and Mazda Motor Corp. said Friday they plan to spend $1.6 billion to set up a joint-venture auto manufacturing plant in the U.S. — a move that will create up to 4,000 jobs. (AP Photo/Eugene Hoshiko)